139 related articles for article (PubMed ID: 30615197)
1. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes T
Aqel SI; Kraus EE; Jena N; Kumari V; Granitto MC; Mao L; Farinas MF; Zhao EY; Perottino G; Pei W; Lovett-Racke AE; Racke MK; Fuchs JR; Li C; Yang Y
Clin Exp Immunol; 2019 May; 196(2):215-225. PubMed ID: 30615197
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway.
Xie Y; Jin C; Sang H; Liu W; Wang J
Inflammation; 2023 Oct; 46(5):1626-1638. PubMed ID: 37227550
[TBL] [Abstract][Full Text] [Related]
3. TREM-2 Drives Development of Multiple Sclerosis by Promoting Pathogenic Th17 Polarization.
Qu S; Hu S; Xu H; Wu Y; Ming S; Zhan X; Wang C; Huang X
Neurosci Bull; 2024 Jan; 40(1):17-34. PubMed ID: 37498431
[TBL] [Abstract][Full Text] [Related]
4. microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
Fujiwara M; Raheja R; Garo LP; Ajay AK; Kadowaki-Saga R; Karandikar SH; Gabriely G; Krishnan R; Beynon V; Paul A; Patel A; Saxena S; Hu D; Healy BC; Chitnis T; Gandhi R; Weiner HL; Murugaiyan G
J Clin Invest; 2022 May; 132(10):. PubMed ID: 35298438
[TBL] [Abstract][Full Text] [Related]
5. Immunoswitch Nanomodulators Enable Active Targeting and Selective Proliferation of Regulatory T Cells for Multiple Sclerosis Therapy.
Wang X; Liu Z; Wang D; Zhang Y; Zhang H; Xue F; Wang X; Tang Z; Han X
ACS Nano; 2024 Jan; 18(1):770-782. PubMed ID: 38113242
[TBL] [Abstract][Full Text] [Related]
6. IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.
Basu R; Whitley SK; Bhaumik S; Zindl CL; Schoeb TR; Benveniste EN; Pear WS; Hatton RD; Weaver CT
Nat Immunol; 2015 Mar; 16(3):286-95. PubMed ID: 25642823
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain.
Gandy KAO; Zhang J; Nagarkatti P; Nagarkatti M
J Neuroimmune Pharmacol; 2019 Sep; 14(3):462-477. PubMed ID: 30941623
[TBL] [Abstract][Full Text] [Related]
8. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39
do Sacramento PM; Sales M; Kasahara TM; Monteiro C; Oyamada H; Dias ASO; Lopes L; Castro CT; Rossi ÁD; Milioni LM; Agrawal A; Alvarenga R; Vasconcelos CC; Bento CAM
Cell Mol Life Sci; 2022 May; 79(6):298. PubMed ID: 35585332
[TBL] [Abstract][Full Text] [Related]
9. Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6.
Gao W; Thompson L; Zhou Q; Putheti P; Fahmy TM; Strom TB; Metcalfe SM
Cell Cycle; 2009 May; 8(9):1444-50. PubMed ID: 19342884
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis.
Petersen-Cherubini CL; Murphy SP; Xin M; Liu Y; Deffenbaugh JL; Jahan I; Rau CN; Yang Y; Lovett-Racke AE
Eur J Immunol; 2024 Jan; 54(1):e2350561. PubMed ID: 37850588
[TBL] [Abstract][Full Text] [Related]
11. The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation
Gaunt CM; Rainbow DB; Mackenzie RJ; Jarvis LB; Mousa HS; Cunniffe N; Georgieva Z; Brown JW; Coles AJ; Jones JL
Front Immunol; 2021; 12():712241. PubMed ID: 34447379
[TBL] [Abstract][Full Text] [Related]
12. [Immune Regulation by TNF Receptor-associated Factor 5].
So T
Yakugaku Zasshi; 2024; 144(5):489-496. PubMed ID: 38692922
[TBL] [Abstract][Full Text] [Related]
13. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.
Wagner A; Wang C; Fessler J; DeTomaso D; Avila-Pacheco J; Kaminski J; Zaghouani S; Christian E; Thakore P; Schellhaass B; Akama-Garren E; Pierce K; Singh V; Ron-Harel N; Douglas VP; Bod L; Schnell A; Puleston D; Sobel RA; Haigis M; Pearce EL; Soleimani M; Clish C; Regev A; Kuchroo VK; Yosef N
Cell; 2021 Aug; 184(16):4168-4185.e21. PubMed ID: 34216539
[TBL] [Abstract][Full Text] [Related]
14. Low-dose IL-2 Treatment Rescues Cognitive Deficits by Repairing the Imbalance Between Treg and Th17 Cells at the Middle Alzheimer's Disease Stage.
Yuan L; Xie L; Zhang H; Zhang Y; Wei Y; Feng J; Cui L; Tian R; Feng J; Yu D; Lv C
J Neuroimmune Pharmacol; 2023 Dec; 18(4):674-689. PubMed ID: 37962810
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-1β-mediated interleukin-1 receptor-associated kinase 4 phosphorylation by zinc leads to repression of memory T helper type 17 response in humans.
Lee H; Kim B; Choi YH; Hwang Y; Kim DH; Cho S; Hong SJ; Lee WW
Immunology; 2015 Dec; 146(4):645-56. PubMed ID: 26407164
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression.
Chang SH; Chung Y; Dong C
J Biol Chem; 2010 Dec; 285(50):38751-5. PubMed ID: 20974859
[TBL] [Abstract][Full Text] [Related]
17. Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells.
Lai R; Xian D; Xiong X; Yang L; Song J; Zhong J
Redox Rep; 2018 Dec; 23(1):130-135. PubMed ID: 29630472
[TBL] [Abstract][Full Text] [Related]
18. The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.
Bayer AL; Pugliese A; Malek TR
Immunol Res; 2013 Dec; 57(1-3):197-209. PubMed ID: 24214027
[TBL] [Abstract][Full Text] [Related]
19. CTRP4/interleukin-6 receptor signaling ameliorates autoimmune encephalomyelitis by suppressing Th17 cell differentiation.
Cao L; Deng J; Chen W; He M; Zhao N; Huang H; Ling L; Li Q; Zhu X; Wang L
J Clin Invest; 2023 Nov; 134(4):. PubMed ID: 38015631
[TBL] [Abstract][Full Text] [Related]
20. A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.
Sha Y; Markovic-Plese S
Self Nonself; 2011 Jan; 2(1):35-42. PubMed ID: 21776333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
